David P. Lane

Activation of the cryptic DNA binding function of mutant forms of p53.

D. Lane, T. Hupp, C. Midgley, 1993, Nucleic acids research.

Strategies for manipulating the p53 pathway in the treatment of human cancer.

D. Lane, T. Hupp, K. Ball, 2000, The Biochemical journal.

The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.

D. Lane, S. Hansen, C. Midgley, 1998, Journal of molecular biology.

Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.

A. Fersht, D. Lane, P. Nikolova, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Molecular characterization of the hdm2-p53 interaction.

S F Howard, D. Lane, C. García-echeverría, 1997, Journal of molecular biology.

Activation of p53 by scaffold-stabilised expression of Mdm2-binding peptides: visualisation of reporter gene induction at the single-cell level

D. Lane, L. Stevenson, G. Karlsson, 2004, British Journal of Cancer.

Identification of novel mdm2 binding peptides by phage display.

D. Lane, C. García-echeverría, P. Chène, 1996, Oncogene.